Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation (original) (raw)
Booth-Jones M, Jacobsen PB, Ransom S, Soety E . Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplant 2005; 36: 695–702. ArticleCASPubMed Google Scholar
Syrjala KL, Dikmen S, Langer SL, Roth-Roemer S, Abrams JR . Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood 2004; 104: 3386–3392. ArticleCASPubMed Google Scholar
Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JB et al. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol 2011; 29: 2397–2404. ArticlePubMedPubMed Central Google Scholar
Scherwath A, Schirmer L, Kruse M, Ernst G, Eder M, Dinkel A et al. Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study. Psychooncology 2013; 22: 1509–1516. ArticlePubMed Google Scholar
Ahles TA, Root JC, Ryan EL . Cancer- and cancer treatment–associated cognitive change: an update on the state of the science. J Clin Oncol 2012; 30: 3675–3686. ArticleCASPubMedPubMed Central Google Scholar
Saykin AJ, Ahles TA, McDonald BC . Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 2003; 8: 201–216. ArticlePubMed Google Scholar
Harder H, Van Gool AR, Duivenvoorden HJ, Cornelissen JJ, Eijkenboom WM, Barge RM et al. Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: two-year follow-up results. Eur J Cancer 2007; 43: 2052–2059. ArticlePubMed Google Scholar
Meadows ME, Chang G, Jones JA, Antin JR, Orav EJ . Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome. Arch Clin Neuropsychol 2013; 28: 363–374. ArticlePubMedPubMed Central Google Scholar
Meyers CA, Albitar M, Estey E . Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005; 104: 788–793. ArticleCASPubMed Google Scholar
Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012; 47: 337–341. ArticleCASPubMedPubMed Central Google Scholar
National Comprehensive Cancer Network. Survivorship, Version 2.2014: National Comprehensive Cancer Network; 2014.
Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335–2343. ArticleCASPubMed Google Scholar
Kirchhoff AC, Leisenring W, Syrjala KL . Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv 2010; 4: 33–44. ArticlePubMedPubMed Central Google Scholar
Socie G, Mary JY, Esperou H, Robert DV, Aractingi S, Ribaud P et al. Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2001; 113: 194–201. ArticleCASPubMed Google Scholar
Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL et al. Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol 2001; 19: 242–252. ArticleCASPubMed Google Scholar
Von Ah D, Jansen CE, Allen DH . Evidence-based interventions for cancer- and treatment-related cognitive impairment. Clin J Oncol Nurs 2014; 18 (suppl): 17–25. ArticlePubMed Google Scholar
Alosco ML, Spitznagel MB, Cohen R, Sweet LH, Colbert LH, Josephson R et al. Cognitive impairment is independently associated with reduced instrumental activities of daily living in persons with heart failure. J Cardiovasc Nurs 2012; 27: 44–50. ArticlePubMedPubMed Central Google Scholar
Alosco ML, Spitznagel MB, van Dulmen M, Raz N, Cohen R, Sweet LH et al. Cognitive function and treatment adherence in older adults with heart failure. Psychosom Med 2012; 74: 965–973. ArticlePubMedPubMed Central Google Scholar
Albert SM, Flater SR, Clouse R, Todak G, Stern Y, Marder K et al. Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy. AIDS Behav 2003; 7: 329–338. ArticlePubMed Google Scholar
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004; 10: 317–331. ArticlePubMed Google Scholar
Thames AD, Arentoft A, Rivera-Mindt M, Hinkin CH . Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study. J Clin Exp Neuropsychol 2013; 35: 49–58. ArticlePubMed Google Scholar
Manning KJ, Clarke C, Lorry A, Weintraub D, Wilkinson JR, Duda JE et al. Medication management and neuropsychological performance in Parkinson's disease. Clin Neuropsychol 2012; 26: 45–58. ArticlePubMed Google Scholar
Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV . Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res 2003; 63: 49–58. ArticlePubMed Google Scholar
Ruscin JM, Semla TP . Assessment of medication management skills in older outpatients. Ann Pharmacother 1996; 30: 1083–1088. ArticleCASPubMed Google Scholar
Patton DE, Woods SP, Franklin D Jr., Cattie JE, Heaton RK, Collier AC et al. Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV. AIDS Behav 2012; 16: 2286–2296. ArticlePubMedPubMed Central Google Scholar
Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE . Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 2003; 9: 967–982. ArticlePubMed Google Scholar
Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA . The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 2005; 59: 60–70. ArticlePubMed Google Scholar
Wefel JS, Vardy J, Ahles T, Schagen SB . International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 2011; 12: 703–708. ArticlePubMed Google Scholar
Heaton RK, Miller SW, Taylor MJ, Grant I . Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults, Professional Manual. PAR: Lutz, FL, USA, 2004. Google Scholar
Wechsler D . Wechsler Adult Intelligence Scale. Third Edition: Administration and scoring manual: San Antonio, TX: The Psychological Corporation, 1997. Google Scholar
Wechsler D WMS-III: Wechsler Memory Scale Administration and Scoring Manual:396 Psychological Corporation, San Antonio, TX, 1997.
Benedict RH, Schretlen D, Groninger L, Brandt J . Hopkins Verbal Learning Test - revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 1998; 12: 43–65. Article Google Scholar
Brandt J . The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991; 5: 125–142. Article Google Scholar
The Neuropsychology Center Manual for Administration and Scoring, Trail Making Test. The Neuropsychology Center : Plano, TX, USA, 2008.
Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK . Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment 1999; 6: 147–178. ArticleCASPubMed Google Scholar
Strauss E, Spreen O, Sherman EMS, Spreen O . A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press : Oxford; New York, 2006; 1216. Google Scholar
Brandt J, Benedict RH . Hopkins Verbal Learning Test - Revised, Professional Manual. PAR: Lutz, FL, USA, 2001. Google Scholar
Broadbent DE, Cooper PF, FitzGerald P, Parkes KR . The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982; 21: 1–16. ArticlePubMed Google Scholar
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376. ArticleCASPubMed Google Scholar
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912–2919. ArticleCASPubMedPubMed Central Google Scholar
Lezak MD, Howieson DB, Loring DW . Neuropsychological Assessment. Oxford University Press: New York, 2004. Google Scholar
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E . Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997; 13: 63–74. ArticleCASPubMed Google Scholar
Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30A: 1326–1336. ArticleCASPubMed Google Scholar
Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT . The memorial symptom assessment scale short form (MSAS-SF). Cancer 2000; 89: 1162–1171. ArticleCASPubMed Google Scholar
Radloff LS . The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401. Article Google Scholar
Karnofsky DA, Burchenal JH . MacLeod CM (ed.) Evaluation of Chemotherapeutic Agents; Symposium Held at the New York Academy of Medicine, Mar 25 and 26, 1948. Columbia University Press: New York, 1949, 196. Google Scholar
Schag CC, Heinrich RL, Ganz PA . Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 1984; 2: 187–193. ArticleCASPubMed Google Scholar
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828. CASPubMed Google Scholar
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956. ArticlePubMed Google Scholar
MacMillan ML, Weisdorf DJ, Wagner JE, DeFor TE, Burns LJ, Ramsay NK et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant 2002; 8: 387–394. ArticleCASPubMed Google Scholar
Montgomery DC, Peck EA, Vining GG . Introduction to Linear Regression Analysis. Wiley-Interscience: Hoboken, NJ, USA, 2006; 612. Google Scholar
Woods SP, Moore DJ, Weber E, Grant I . Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 2009; 19: 152–168. ArticlePubMedPubMed Central Google Scholar
Pullens MJ, De Vries J, Roukema JA . Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology 2010; 19: 1127–1138. ArticlePubMed Google Scholar
Gisslen M, Price RW, Nilsson S . The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis 2011; 11: 356. ArticlePubMedPubMed Central Google Scholar
McCutchan JA, Wu JW, Robertson K, Koletar SL, Ellis RJ, Cohn S et al. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS 2007; 21: 1109–1117. ArticlePubMed Google Scholar
Farmer KC . Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074–1090. ArticleCASPubMed Google Scholar
Ho L, Akada K, Messner H, Kuruvilla J, Wright J, Seki JT . Pharmacist's role in improving medication safety for patients in an allogeneic hematopoietic cell transplant ambulatory clinic. Can J Hosp Pharm 2013; 66: 110–117. PubMedPubMed Central Google Scholar